Skip to main content

Equi-Jec 6

This page contains information on Equi-Jec 6 for veterinary use.
The information provided typically includes the following:
  • Equi-Jec 6 Indications
  • Warnings and cautions for Equi-Jec 6
  • Direction and dosage information for Equi-Jec 6

Equi-Jec 6

This treatment applies to the following species:
Company: Boehringer Ingelheim

Encephalomyelitis-Rhinopneumonitis-Influenza-West Nile Virus Vaccine

Eastern & Western, Killed Virus, Tetanus Toxoid

For Use In Animals Only

Equi-Jec 6 Indications

For vaccination of healthy horses 4 months of age or older as an aid in the prevention of disease caused by eastern and western encephalomyelitis and tetanus; as an aid in the reduction of respiratory disease caused by equine influenza virus (EIV) (product contains Kentucky Lineage (KY/95), Florida sublineage clade 1 (OH/03), and Eurasian Newmarket/2/93 (NM 2/93) EIV strains), and equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4); as an aid in the reduction of severity of clinical disease, and an aid in the prevention of viremia and mortality caused by west nile virus (WNV). Safe for use in pregnant mares. The duration of immunity (DOI) is at least 6 months for OH/03 and at least 12 months for WNV.

Directions and dosage: Shake well before use. Using aseptic technique, vaccinate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian is recommended.


Store at 35-46°F (2-8°C). Do not freeze. Do not vaccinate within 21 days before slaughter. Do not mix with other products. In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician.

Preservatives: Gentamicin and Amphotericin B.

Equi-Jec® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH. Used under license.

© 2017 Boehringer Ingelheim Vetmedica, Inc. All rights reserved.

US Patent Nos. 7,309,598; 8,697,089; 8,821,889; and 9,517,259.

US Patent Nos. 7,572,620; 8,535,685; 8,784,838; 9,180,181; and 9,492,530, used under license.

Manufactured/Distributed By: Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506

Phone: 866-638-2226

VLN/PCN 124/4855.24

1 Dose/1 mL


CPN: 1028309.0

Telephone:   800-325-9167
Fax:   816-236-2717
This service and data are provided "AS IS". DVMetrics and assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics and services and data. See the terms of use for further details.

Copyright © 2022 Animalytix LLC. Updated: 2021-11-29